BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, Marrone A, Nascimbeni F, Florio A, Loria P. Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. World J Gastroenterol 2014; 20(13): 3410-3417 [PMID: 24707124 DOI: 10.3748/wjg.v20.i13.3410]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3410.htm
(400) (387) (0) (0) (12487) (139)
Number Citing Articles
1
Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678546
2
Amin R. Soliman, Rabab M. Ahmed, Mahmoud Soliman, Ahmed Abdallah, Bahaa Zayed. The effect of co-infection with hepatitis B and hepatitis C viruses on the prevalence of proteinuria and loss of renal function: a single-center experience. The Egyptian Journal of Internal Medicine 2018; 30(4) doi: 10.4103/ejim.ejim_51_18
3
Hitesh Sharma, Karen Mossman, Richard C. Austin. Fatal attractions that trigger inflammation and drive atherosclerotic disease. European Journal of Clinical Investigation 2024; 54(5) doi: 10.1111/eci.14169
4
Roger Bedimo, Oladapo Abodunde. Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients. Current HIV/AIDS Reports 2016; 13(6) doi: 10.1007/s11904-016-0333-9
5
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis. Revista Clínica Española 2021; 221(10) doi: 10.1016/j.rce.2019.10.010
6
Sichao WANG, Weixia SUN, Yiping CHENG, Lei WANG, Shizhan MA, Fei JING, Xiujuan ZHANG, Xinli ZHOU. Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity. Minerva Endocrinology 2025; 50(1) doi: 10.23736/S2724-6507.21.03424-6
7
Luigi Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone, Mauro Giordano, Rosa Zampino. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. International Journal of Molecular Sciences 2016; 17(6) doi: 10.3390/ijms17060803
8
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínica. Revista Clínica Española 2019; 219(6) doi: 10.1016/j.rce.2018.12.007
9
Luigi Elio Adinolfi, Emanuele Durante Mangoni, Aldo Marrone, Rosa Zampino, Luca Rinaldi. Liver Diseases. 2020;  doi: 10.1007/978-3-030-24432-3_17
10
Vikash Jaiswal, Song Peng Ang, Muhammad Hanif, Mayank Jha, Vikash Kumar, Abdelmonem Siddiq, Bhavyakumar Vachhani, Anupam Halder, Michelle Koifman, Herby Jeanty, Siddharath Soni, Madeeha Subhan Waleed, Tushar Kumar, Helen Huang, Dhrubajyoti Bandyopadhyay. Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis. IJC Heart & Vasculature 2023; 49 doi: 10.1016/j.ijcha.2023.101270
11
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología 2020; 40(3) doi: 10.1016/j.nefro.2019.07.007
12
Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon L. Hunt. Treatment with ledipasvir and sofosbuvir improves patient‐reported outcomes: Results from the ION‐1, ‐2, and ‐3 clinical trials. Hepatology 2015; 61(6) doi: 10.1002/hep.27724
13
Jose Gabriel Solis, Ervin Saul Enciso López, Aleida Bautista Santos, Juan Carlos Anda Garay, Jose Luis Calixto Rodríguez, Rosalba Moreno Alcántar, Luis Montiel López. Effect of Antiviral Agents on Atherosclerosis in Patients with Chronic Hepatitis C. Archives of Medical Research 2021; 52(7) doi: 10.1016/j.arcmed.2021.04.009
14
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología (English Edition) 2023; 46(1) doi: 10.1016/j.gastre.2022.03.008
15
O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen, T.-P. Tuomainen. Hepatitis C and risk of coronary atherosclerosis – A systematic review. Public Health 2016; 138 doi: 10.1016/j.puhe.2016.04.005
16
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 2016; 10(3) doi: 10.1007/s12072-015-9684-3
17
Qi-tao Huang, Li-lin Hang, Mei Zhong, Yun-fei Gao, Man-ling Luo, Yan-hong Yu. Maternal HCV infection is associated with intrauterine fetal growth disturbance. Medicine 2016; 95(35) doi: 10.1097/MD.0000000000004777
18
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Infection 2019; 47(1) doi: 10.1007/s15010-018-1209-2
19
Andrea TASSI, Stefano GITTO, Chiara PIRAS, Carmela CURSARO, Tatiana ALICANDRO, Marzia MARGOTTI, Marco RIVI, Pietro ANDREONE. Cognitive, neurological and psychiatric disorders occurring in Hepatitis C Virus infection. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.21.07388-2
20
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegado. Nefrología 2019; 39(5) doi: 10.1016/j.nefro.2019.01.002
21
Mu-Chi Chung, Tung-Min Yu, Laing-You Wu, Ming-Ju Wu, Jeng-Jer Shieh, Chi-Jung Chung. SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis. JAMA Network Open 2026; 9(2) doi: 10.1001/jamanetworkopen.2025.60429
22
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2) doi: 10.1111/apt.15575
23
Mirela Pavicic Ivelja, Ivo Ivic, Kresimir Dolic, Antonio Mestrovic, Nikola Perkovic, Stipan Jankovic, Rayaz A Malik. Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color Doppler. PLOS ONE 2019; 14(6) doi: 10.1371/journal.pone.0218206
24
Ahmed A. Elamragy, Juliette Bahgat Mesak, Wael Mohamed Elnaggar, Karim Said, Marwa Sayed Meshaal. Speckle Tracking Echocardiography: The Secret Key To Predicting Poor Outcomes in Infective Endocarditis. Cor et Vasa 2026; 68(1) doi: 10.33678/cor.2025.104
25
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopenia. The Egyptian Journal of Internal Medicine 2019; 31(3) doi: 10.4103/ejim.ejim_14_19
26
Joshua S Davis, Melissa Young, Sandra Lennox, Tracey Jones, Kim Piera, Robert Pickles, Stephen Oakley. The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function. Antiviral Therapy 2018; 23(8) doi: 10.3851/IMP3257
27
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantation. Nature Reviews Nephrology 2015; 11(3) doi: 10.1038/nrneph.2015.5
28
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis. Revista Clínica Española (English Edition) 2021; 221(10) doi: 10.1016/j.rceng.2019.10.014
29
Olubunmi O. Olubamwo, Ifeoma N. Onyeka, Juhani Miettola, Jussi Kauhanen, Tomi‐Pekka Tuomainen. Hepatitis C as a risk factor for carotid atherosclerosis – a systematic review. Clinical Physiology and Functional Imaging 2016; 36(4) doi: 10.1111/cpf.12229
30
Evgeniy V. Kryukov, Dmitry V. Cherkashin, Vladimir V. Saluhov, Konstantin V. Matjushenko, Aleksey D. Sobolev, Nikolaj N. Shcherbina. Extrahepatic manifestations of chronic viral hepatitis C. Bulletin of the Russian Military Medical Academy 2022; 24(2) doi: 10.17816/brmma103982
31
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.007
32
H. Husseinzadeh, T. Chiasakul, P. A. Gimotty, B. Pukenas, R. Wolf, M. Kelty, E. Chiang, P. F. Fogarty, A. Cuker. Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B. Haemophilia 2018; 24(2) doi: 10.1111/hae.13398
33
José M. Ferro, Sofia Oliveira. Neurologic Manifestations of Gastrointestinal and Liver Diseases. Current Neurology and Neuroscience Reports 2014; 14(10) doi: 10.1007/s11910-014-0487-z
34
Jakob Van Herck, Jef Verbeek, Hannah van Malenstein, Wim Laleman, David Cassiman, Chris Verslype, Schalk van der Merwe, Ina Jochmans, Mauricio Sainz-Barriga, Diethard Monbaliu, Jacques Pirenne, Frederik Nevens. Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study. Transplantation Proceedings 2021; 53(5) doi: 10.1016/j.transproceed.2021.02.025
35
Sha Li, Jian-Jun Li. PCSK9: A key factor modulating atherosclerosis. Journal of Atherosclerosis and Thrombosis 2015; 22(3) doi: 10.5551/jat.27615
36
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología (English Edition) 2020; 40(3) doi: 10.1016/j.nefroe.2020.06.005
37
Helen Kovari, Andri Rauch, Roger Kouyos, Mathieu Rougemont, Matthias Cavassini, Patrick Schmid, Marcel Stöckle, Enos Bernasconi, Rainer Weber, Bruno Ledergerber. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study. Clinical Infectious Diseases 2017; 64(4) doi: 10.1093/cid/ciw809
38
Hong Jiang, Yi-fan Zhang, Ru-chao Zhang, Ya-nan Xing. Therapeutic, preventive, and pathogenetic advances in viral hepatitis. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1939337
39
Dina Johar, Ahmed Hamed Bedair El-Assal, Mahmoud Mohamed Abou-El-Makarem, Essam Foad A. Hammouda, Mohamed Soliman Hegazy, Samy Zaky. Do oxidized low-density lipoproteins link to extra hepatic manifestations in chronic, non-cirrhotic HCV patients?. Metabolism Open 2025; 25 doi: 10.1016/j.metop.2024.100339
40
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infections. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
41
Luigi Elio Adinolfi, Luca Rinaldi, Riccardo Nevola. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?. World Journal of Gastroenterology 2018; 24(41): 4617-4621 doi: 10.3748/wjg.v24.i41.4617
42
Shih-Yi Lin, Cheng-Li Lin, Wei-Shan Chen, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Chung Y Hsu, Chia-Hung Kao. Association Between Alcoholic Cirrhosis and Hemorrhagic Stroke: A Nationwide Population-based Study. Alcohol and Alcoholism 2019; 54(3) doi: 10.1093/alcalc/agz025
43
Tracey G Simon, Adeel A Butt. Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World Journal of Gastroenterology 2015; 21(27): 8293-8303 doi: 10.3748/wjg.v21.i27.8293
44
Melissa Bello-Perez, Alberto Falco, Beatriz Novoa, Luis Perez, Julio Coll, Keivan Zandi. Hydroxycholesterol binds and enhances the anti-viral activities of zebrafish monomeric c-reactive protein isoforms. PLOS ONE 2019; 14(1) doi: 10.1371/journal.pone.0201509
45
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis. Revista Clínica Española (English Edition) 2019; 219(6) doi: 10.1016/j.rceng.2019.02.008
46
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030355
47
Stefano Gitto, Arrigo F.G. Cicero, Elisabetta Loggi, Marina Giovannini, Fabio Conti, Elena Grandini, Valeria Guarneri, Alessandra Scuteri, Giovanni Vitale, Carmela Cursaro, Claudio Borghi, Pietro Andreone. Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment. Annals of Hepatology 2018; 17(1) doi: 10.5604/01.3001.0010.7536
48
Lucija Virović Jukić, Dominik Kralj. Update on Hepatitis C. 2017;  doi: 10.5772/intechopen.70728
49
Abdul-Quddus Mohammed, Ranshaka Auckle, Hai-Ling Li, Si-Ling Xu, Lu Liu, Dong-Dong Zhao, Wen-Liang Che. Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response. The American Journal of the Medical Sciences 2018; 355(6) doi: 10.1016/j.amjms.2018.02.001
50
Alejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, Dariela Micheloud, Teresa Aldámiz-Echevarría, Chiara Fanciulli, Salvador Resino, Sarah L Pett. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0179493
51
Mohammad Said Ramadan, Filomena Boccia, Simona Maria Moretto, Fabrizio De Gregorio, Massimo Gagliardi, Domenico Iossa, Emanuele Durante-Mangoni, Rosa Zampino. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Journal of Clinical Medicine 2022; 11(19) doi: 10.3390/jcm11195781
52
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 2015; 10(5) doi: 10.1097/COH.0000000000000175
53
Laith Al‐Rabadi, Terry Box, Girish Singhania, Catreena Al‐Marji, Adhish Agarwal, Isaac Hall, Craig E. Gordon, Huy Tran. Rationale for treatment of hepatitis C virus infection in end‐stage renal disease patients who are not kidney transplant candidates. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12656
54
Christopher Dächert, Evgeny Gladilin, Marco Binder. Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host Factors. Viruses 2019; 12(1) doi: 10.3390/v12010036
55
Maria Mazzitelli, Carlo Torti, Jolanda Sabatino, Greta Luana D’Ascoli, Chiara Costa, Vincenzo Pisani, Elena Raffetti, Salvatore De Rosa, Alessio Strazzulla, Alfredo Focà, Maria Carla Liberto, Ciro Indolfi. Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3426-9
56
Tomohisa Nagano, Nobuyoshi Seki, Yoichi Tomita, Tomonori Sugita, Yuta Aida, Munenori Itagaki, Satoshi Sutoh, Hiroshi Abe, Akihito Tsubota, Yoshio Aizawa. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions. International Journal of Molecular Sciences 2015; 16(9) doi: 10.3390/ijms160920576
57
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrived. Nefrología (English Edition) 2019; 39(5) doi: 10.1016/j.nefroe.2019.01.009
58
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis B Virus and Chronic Kidney Disease: a Systematic Review and Meta-analysis. Annals of Hepatology 2017; 16(1) doi: 10.5604/16652681.1226813
59
Steven R. Horbal, Patrick X. Belancourt, Peng Zhang, Sven A. Holcombe, Sameer Saini, Stewart C. Wang, Anne E. Sales, Grace L. Su. Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease. Digestive Diseases and Sciences 2024; 69(7) doi: 10.1007/s10620-024-08450-5
60
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Journal of Nephrology 2018; 31(5) doi: 10.1007/s40620-018-0523-1
61
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infection. Medical Council 2020; (21) doi: 10.21518/2079-701X-2019-21-248-253
62
Hong-Juan Fu, Li-Bo Zhao, Ju-Jun Xue, Zhi-Xuan Wu, Yue-Ping Huang, Wei Liu, Zhan Gao. Elevated Serum Homocysteine (Hcy) Levels May Contribute to the Pathogenesis of Cerebral Infarction. Journal of Molecular Neuroscience 2015; 56(3) doi: 10.1007/s12031-015-0497-6
63
Melissa Bello-Perez, Alberto Falco, Regla Medina-Gali, Patricia Pereiro, Jose Antonio Encinar, Beatriz Novoa, Luis Perez, Julio Coll. Neutralization of viral infectivity by zebrafish c-reactive protein isoforms. Molecular Immunology 2017; 91 doi: 10.1016/j.molimm.2017.09.005
64
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Riccardo Nevola, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vito Di Marco, Antonio Solano, Rosa Lombardi, Mauro Giordano, Antonio Craxi, Alessandro Perrella, Celestino Sardu, Raffaele Marfella, Teresa Salvatore, Luigi Elio Adinolfi, Luca Rinaldi. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2021; 31(8) doi: 10.1016/j.numecd.2021.04.016
65
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
66
Mauro Viganò, Massimo Colombo. Extrahepatic Manifestations of Hepatitis C Virus. Gastroenterology Clinics of North America 2015; 44(4) doi: 10.1016/j.gtc.2015.07.006
67
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Annals of Hepatology 2018; 17(3) doi: 10.5604/01.3001.0011.7382
68
Fiona Marra, Christoph Höner zu Siederdissen, Saye Khoo, David Back, Michael Schlag, Sivi Ouwerkerk‐Mahadevan, Ceyhun Bicer, Isabelle Lonjon‐Domanec, Wolfgang Jessner, Maria Beumont‐Mauviel, Ronald Kalmeijer, Markus Cornberg. Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications. British Journal of Clinical Pharmacology 2018; 84(5) doi: 10.1111/bcp.13519
69
Fan Z. Caprio, Chen Lin. Warlow's Stroke. 2019;  doi: 10.1002/9781118492390.ch7
70
Juan C. Lopez-Delgado, Alessandro Putzu, Giovanni Landoni. The importance of liver function assessment before cardiac surgery: A narrative review. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.1053019
71
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
72
Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, Guglielmo Borgia. Beclabuvir for the treatment of hepatitis C. Expert Opinion on Investigational Drugs 2015; 24(8) doi: 10.1517/13543784.2015.1059820
73
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
74
Patrice Cacoub, Cloé Comarmond. New insights into HCV-related rheumatologic disorders: A review. Journal of Advanced Research 2017; 8(2) doi: 10.1016/j.jare.2016.07.005
75
Fabrizio Fabrizi, Piergiorgio Messa. Managing hepatitis C therapy failures and chronic kidney disease. Expert Review of Clinical Pharmacology 2018; 11(11) doi: 10.1080/17512433.2018.1534202
76
Xin Su, Xin Zhao, Jia‐Long Deng, Song‐Nan Li, Xin Du, Jian‐Zeng Dong, Chang‐Sheng Ma. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2021; 28(4) doi: 10.1111/jvh.13469
77
Çetin Karaca. Viral Hepatitis: Chronic Hepatitis C. 2019;  doi: 10.1007/978-3-030-03757-4_10
78
Fanny Domont, Patrice Cacoub. Chronic hepatitis C virus infection, a new cardiovascular risk factor?. Liver International 2016; 36(5) doi: 10.1111/liv.13064
79
M L Zubkin, V I Chervinko, Yu V Ovchinnikov, E V Kryukov, O N Kotenko. Chronic HCV infection: An internist’s opinion (Part 2). Terapevticheskii arkhiv 2016; 88(11) doi: 10.17116/terarkh20168811138-148
80
Jing-Hua Li, Ning Zhu, Ying-Bin Min, Xiang-Zhou Shi, Yun-You Duan, Yi-Lin Yang. Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0910-z
81
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2) doi: 10.1016/j.jare.2016.06.001
82
Hamdy A. Sliem, Ahmed S. Salem, Walid M. Hussien, Hind R.A. El Sayed. Arterial wall structural changes in noncirrhotic chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology 2019; 31(11) doi: 10.1097/MEG.0000000000001429
83
Peng Ren, Yulong Zhao, Xue Li, Jing Xie, Xingxing Liao, Qiang Luo, Xu Liu, Jiameng Li, Yuzhen Fan, Xinyi Cheng, Xinyao Fu, Junjie Zhou, Xiaoyun Wu. Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behaviour in atherosclerotic mice by inhibiting nerve cell ferroptosis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1599570
84
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera, Annalisa Amelia, Maria Chiara Fascione, Stefano Ballestri, Dante Romagnoli, Rosa Zampino, Riccardo Nevola, Enrica Baldelli, Natalina Iuliano, Valerio Rosato, Amedeo Lonardo, Luigi Elio Adinolfi. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology 2017; 23(8): 1458-1468 doi: 10.3748/wjg.v23.i8.1458
85
Hongyi Zhou, Courtney Astore, Jeffrey Skolnick. PHEVIR: an artificial intelligence algorithm that predicts the molecular role of pathogens in complex human diseases. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25412-x
86
Timothy C Durazzo, Eric P Kraybill, Lauren H Stephens, April C May, Dieter J Meyerhoff. Pro-atherogenic medical conditions are associated with widespread regional brain metabolite abnormalities in those with alcohol use disorder. Alcohol and Alcoholism 2024; 59(5) doi: 10.1093/alcalc/agae055
87
Cristina Vassalle, Antonella Meloni, Laura Pistoia, Alessia Pepe. LIVER PANCREAS HEART TRIANGLE AND HCV IN THALASSEMIA: EXPANDING THE HORIZON THROUGH BIOMARKER NETWORKS. International Journal of Hematology and Therapy 2017; 3(1) doi: 10.15436/2381-1404.17.017
88
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
89
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito, Laura Benítez-Gutiérrez, Pablo Barreiro. Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver. Antiviral Therapy 2016; 21(1) doi: 10.3851/IMP2975
90
Patrice Cacoub, Anne Claire Desbois, Cloe Comarmond, David Saadoun. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut 2018; 67(11) doi: 10.1136/gutjnl-2018-316234
91
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet need. World Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
92
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología 2023; 46(1) doi: 10.1016/j.gastrohep.2022.03.007
93
Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego. Extrahepatic manifestations of chronic hepatitis C virus infection. Digestive and Liver Disease 2014; 46 doi: 10.1016/j.dld.2014.10.005
94
Yi-Ting Huang, Yao-Chun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Tai-Hsuan Lai, Chien-Jen Chen, Yen-Tsung Huang. Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study. Journal of Epidemiology 2025; 35(1) doi: 10.2188/jea.JE20240034
95
José M. Ferro, Pedro Viana, Patrícia Santos. Management of Neurologic Manifestations in Patients with Liver Disease. Current Treatment Options in Neurology 2016; 18(8) doi: 10.1007/s11940-016-0419-0
96
Joji Tani, Tsutomu Masaki, Kyoko Oura, Tomoko Tadokoro, Asahiro Morishita, Hideki Kobara. Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals. Microorganisms 2024; 12(9) doi: 10.3390/microorganisms12091926
97
Hope Onohuean, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Gaber El-Saber Batiha. Covid-19 and development of heart failure: mystery and truth. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10) doi: 10.1007/s00210-021-02147-6
98
Fabrizio Fabrizi, Francesco Negro, Mark Bondin, Patrice Cacoub. Expert Opinion on the Management of Renal Manifestations of Chronic HCV Infection. Antiviral Therapy 2018; 23(1_suppl) doi: 10.3851/IMP3247
99
Tao Zhang, Yuan Jiang, Shuhua Zhang, Tingting Tie, Yan Cheng, Xiaoming Su, Zhu Man, Jing Hou, Li Sun, Meiyuan Tian, Yaogang Zhang, Jianhua Li, Yanyan Ma. The association between homocysteine and ischemic stroke subtypes in Chinese. Medicine 2020; 99(12) doi: 10.1097/MD.0000000000019467
100
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney Disease. Annals of Hepatology 2017; 16(6) doi: 10.5604/01.3001.0010.5275
101
Luigi Elio Adinolfi, Riccardo Nevola, Giacomo Lus, Luciano Restivo, Barbara Guerrera, Ciro Romano, Rosa Zampino, Luca Rinaldi, Ausilia Sellitto, Mauro Giordano, Aldo Marrone. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology 2015; 21(8): 2269-2280 doi: 10.3748/wjg.v21.i8.2269
102
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5) doi: 10.1016/j.autrev.2017.03.004
103
Bernard S. Kadosh, Antoinette S. Birs, Erin Flattery, Maxine Stachel, Kimberly N. Hong, Yuhe Xia, Claudia Gidea, Saima Aslam, Louai Razzouk, Tajinderpal Saraon, Randal Goldberg, Shaline Rao, Victor Pretorius, Nader Moazami, Deane E. Smith, Eric D. Adler, Alex Reyentovich. Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors. Clinical Transplantation 2024; 38(4) doi: 10.1111/ctr.15294
104
Sara C. LaHue, Dolores Torres, Nicole Rosendale, Vineeta Singh. Stroke Characteristics, Risk Factors, and Outcomes in Transgender Adults. The Neurologist 2019; 24(2) doi: 10.1097/NRL.0000000000000226
105
Dante Romagnoli, Alessandra Marrazzo, Stefano Ballestri, Amedeo Lonardo, Marco Bertolotti. Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma. Journal of Clinical Virology 2015; 69 doi: 10.1016/j.jcv.2015.05.023
106
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Digestive and Liver Disease 2018; 50(11) doi: 10.1016/j.dld.2018.08.022
107
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Internal and Emergency Medicine 2018; 13(8) doi: 10.1007/s11739-018-1940-9
108
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12) doi: 10.1016/j.autrev.2016.09.006
109
Meng-Tzu Weng, Ting-Hui Chang, Chien-Chu Lin, Chien-Sheng Wu. Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia. Journal of Microbiology, Immunology and Infection 2023; 56(4) doi: 10.1016/j.jmii.2023.03.007
110
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
111
He Huang, Rongyan Kang, Zhendong Zhao, Yury E. Khudyakov. Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-Analysis. PLoS ONE 2014; 9(9) doi: 10.1371/journal.pone.0106376
112
Claudia Mascia, Miriam Lichtner, Paola Zuccalà, Serena Vita, Tiziana Tieghi, Raffaella Marocco, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Michela Campagna, Francesco Schiavone, Fabio Mengoni, Gianluca Russo, Claudio Maria Mastroianni, Vincenzo Vullo. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clinics and Research in Hepatology and Gastroenterology 2017; 41(6) doi: 10.1016/j.clinre.2017.04.007
113
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 2021; 29(4) doi: 10.1097/CRD.0000000000000314
114
Maria Perticone, Raffaele Maio, Eliezer Joseph Tassone, Giovanni Tripepi, Serena Di Cello, Sofia Miceli, Benedetto Caroleo, Angela Sciacqua, Anna Licata, Giorgio Sesti, Francesco Perticone. Insulin-resistance HCV infection-related affects vascular stiffness in normotensives. Atherosclerosis 2015; 238(1) doi: 10.1016/j.atherosclerosis.2014.11.025
115
Giovanni Targher, Christopher D. Byrne. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 2017; 13(5) doi: 10.1038/nrneph.2017.16
116
Fernando Scudiero, Renato Valenti, Rossella Marcucci, Giuseppe D. Sanna, Anna Maria Gori, Angela Migliorini, Raffaele Vitale, Betti Giusti, Elena De Vito, Giulia Corda, Rita Paniccia, Davide Zirolia, Mario E. Canonico, Guido Parodi. Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome. Journal of the American Heart Association 2020; 9(18) doi: 10.1161/JAHA.120.016441
117
Ciro Romano, Giovanna Cuomo, Roberta Ferrara, Andrea Del Mastro, Sergio Esposito, Ausilia Sellitto, Luigi Elio Adinolfi. Uncommon immune-mediated extrahepatic manifestations of HCV infection. Expert Review of Clinical Immunology 2018; 14(12) doi: 10.1080/1744666X.2018.1538790
118
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus. Hepatitis Research and Treatment 2016; 2016 doi: 10.1155/2016/7629318
119
Kristine S. Alexander, Neil A. Zakai, Steven D. Lidofsky, Peter W. Callas, Suzanne E. Judd, Russell P. Tracy, Mary Cushman, Pavel Strnad. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLOS ONE 2018; 13(3) doi: 10.1371/journal.pone.0194153
120
Patrice Cacoub, Pierre Nahon, Richard Layese, Lorraine Blaise, Anne Claire Desbois, Valérie Bourcier, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, David Zucman, Vincent Di Martino, Corinne Isnard Bagnis, Marianne Ziol, Angela Sutton, Eric Letouze, Françoise Roudot-Thoraval, Etienne Audureau, Pierre Nahon, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Hélène Fontaine, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Vincent Leroy, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Sebastien Dharancy, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, Sophie Hillaire, Vincent Di Martino. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. American Heart Journal 2018; 198 doi: 10.1016/j.ahj.2017.10.024
121
Timothy C Durazzo, Linh-Chi Nguyen, Dieter J Meyerhoff. Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders. Alcohol and Alcoholism 2020; 55(4) doi: 10.1093/alcalc/agaa034
122
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
123
Patrice Cacoub, Cloe Comarmond, Fanny Domont, Léa Savey, Anne C. Desbois, David Saadoun. Extrahepatic manifestations of chronic hepatitis C virus infection. Therapeutic Advances in Infectious Disease 2016; 3(1) doi: 10.1177/2049936115585942
124
Alex Reyentovich, Claudia G. Gidea, Deane Smith, Bonnie Lonze, Zachary Kon, Anthony Fargnoli, Jennifer Pavone, Shaline Rao, Tajinderpal Saraon, Tyler Lewis, Yingzhi Qian, Ira Jacobson, Nader Moazami. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clinical Transplantation 2020; 34(9) doi: 10.1111/ctr.13989
125
Javier Pagan, Marco Ladino, David Roth. Treating hepatitis C virus in dialysis patients: How, when, and why?. Seminars in Dialysis 2019; 32(2) doi: 10.1111/sdi.12764
126
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection. Current HIV/AIDS Reports 2019; 16(5) doi: 10.1007/s11904-019-00466-1
127
Ming V. Lin, Meghan E. Sise, Martha Pavlakis, Beth M. Amundsen, Donald Chute, Anna E. Rutherford, Raymond T. Chung, Michael P. Curry, Jasmine M. Hanifi, Steve Gabardi, Anil Chandraker, Eliot C. Heher, Nahel Elias, Leonardo V. Riella, Chen-Hua Liu. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0158431
128
Maria M. Xu, Patrick A. Murphy, Anthony T. Vella. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation. American Journal of Physiology-Heart and Circulatory Physiology 2019; 316(6) doi: 10.1152/ajpheart.00148.2019
129
Simona Cammarota, Anna Citarella, Antonella Guida, Valeria Conti, Teresa Iannaccone, Maria Elena Flacco, Francesca Bravi, Cristina Naccarato, Antonella Piscitelli, Raffaele Piscitelli, Alfredo Valente, Giulio Calella, Nicola Coppola, Giustino Parruti, Yury E Khudyakov. The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study). PLOS ONE 2019; 14(7) doi: 10.1371/journal.pone.0219396
130
Andrea Pascual-Oliver, Diego Casas-Deza, Carmen Yagüe-Caballero, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens 2024; 13(4) doi: 10.3390/pathogens13040278
131
Michael Clarke, Sarina Falcione, Roobina Boghozian, Raluca Todoran, Yiran Zhang, Maria Guadalupe C. Real, Alexis StPierre, Twinkle Joy, Glen C. Jickling. Viral Infection and Ischemic Stroke: Emerging Trends and Mechanistic Insights. Journal of the American Heart Association 2024; 13(18) doi: 10.1161/JAHA.124.035892
132
Juan Berenguer, Elena Rodríguez‐Castellano, Ana Carrero, Miguel A. Von Wichmann, Marta Montero, María J. Galindo, Josep Mallolas, Manuel Crespo, María J. Téllez, Carmen Quereda, José Sanz, Carlos Barros, Cristina Tural, Ignacio Santos, Federico Pulido, Josep M. Guardiola, Rafael Rubio, Enrique Ortega, María L. Montes, Juan J. Jusdado, Gabriel Gaspar, Herminia Esteban, José M. Bellón, Juan González‐García. Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2017; 66(2) doi: 10.1002/hep.29071
133
Ming-Shyan Lin, Chang-Min Chung, Wey-Yil Lin, Kuo-Liang Wei, Jui Wang, Ying-Ying Lee, Jing-Hong Hu, Tao-Hsin Tung, Yu-Sheng Lin. Antiviral Therapy Reduces Risk of Haemorrhagic Stroke in Patients with HCV Infection: A Nationwide Cohort Study. Antiviral Therapy 2018; 23(1) doi: 10.3851/IMP3172
134
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa, Hiroshi Ito, Giovanni Targher. Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLOS ONE 2015; 10(6) doi: 10.1371/journal.pone.0131138
135
. Experimental and Clinical Transplantation 2017; 15(1) doi: 10.6002/ect.2015.0341
136
Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review. Liver International 2024; 44(5) doi: 10.1111/liv.15876
137
Ismail Elkhattib, Kareem Wael Raafat, Basant Elsayed, Mohamed Elnaggar. Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. World Journal of Hepatology 2025; 17(8): 108678 doi: 10.4254/wjh.v17.i8.108678
138
Patrice Cacoub, Cloé Comarmond. Considering hepatitis C virus infection as a systemic disease. Seminars in Dialysis 2019; 32(2) doi: 10.1111/sdi.12758
139
Dalia A Freekh, Maged W Helmy, Mohamed Said, Noha M El-khodary. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection. Saudi Pharmaceutical Journal 2021; 29(10) doi: 10.1016/j.jsps.2021.08.006
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.